Skip to main content
NewslettersWatchlist

Willow Biosciencesinc(WLLW-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.1500
Day High0.1750
Open:0.1500
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Willow Biosciencesinc

Select a category then submit the form to load news
Newswire.ca
WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF TRANSFORMATIVE RECAPITALIZATION TRANSACTIONS TO FORM ATLAS ENERGY CORP.
Newswire.ca
WILLOW BIOSCIENCES INC. ANNOUNCES CONDITIONAL ACCEPTANCE OF TSX VENTURE EXCHANGE TO LIST PURSUANT TO THE TSXV SANDBOX
Newswire.ca
WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Baystreet
Stocks in play: Willow Biosciences Inc.
Newswire.ca
WILLOW BIOSCIENCES INC. RECEIVES FIRM COMMITMENTS OF $30.0 MILLION UNDER PREVIOUSLY ANNOUNCED RECAPITALIZATION FINANCING
Newswire.ca
WILLOW BIOSCIENCES INC. ANNOUNCES $30.0 MILLION RECAPITALIZATION FINANCING AND PROPOSED APPOINTMENT OF NEW EXECUTIVE TEAM AND BOARD OF DIRECTORS TO FORM ATLAS ENERGY CORP.
Newswire.ca
WILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF SALE OF OPERATING SUBSIDIARY AND MANAGEMENT CHANGES
PR Newswire
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Drug Manufacturers Industry Stocks (WLLW)
Newswire.ca
WILLOW BIOSCIENCES REPORTS 2024 FINANCIAL RESULTS AND UPDATE REGARDING SALE OF OPERATING SUBSIDIARY
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Drug Manufacturers Industry Stocks (WLLW)
PR Newswire
WILLOW ANNOUNCES SALE OF OPERATING SUBSIDIARY
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Healthcare Sector Stocks on TSX (WLLW)
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Drug Manufacturers Industry Stocks (WLLW)
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Drug Manufacturers Industry Stocks (WLLW)
Baystreet
Stocks in play: Willow Biosciences Inc.
Newswire.ca
WILLOW ANNOUNCES INITIATION OF STRATEGIC REVIEW PROCESS
PR Newswire
WILLOW ANNOUNCES CANCELLATION OF PREVIOUSLY ANNOUNCED NON-BROKERED OFFERING TO PURSUE LESS DILUTIVE ALTERNATIVES
PR Newswire
WILLOW ANNOUNCES NON-BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $2.0 MILLION
Baystreet
Stocks in play: Willow Biosciences Inc.
PR Newswire
WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Baystreet
Stocks in play: Willow Biosciences Inc.
PR Newswire
WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO
Newswire.ca
WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT
AllPennyStocks.com
Biotech on An Upswing Following Licensing and Royalty Agreement
Biotech on An Upswing Following Licensing and Royalty Agreement
Newswire.ca
WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.
Newswire.ca
WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Baystreet
Stocks in play: Willow Biosciences Inc.
Newswire.ca
WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY
Newswire.ca
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS
Newswire.ca
WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF UNITS
AI-generated - The Globe and Mail
Willow Biosciences: Top 10 Undervalued Drug Manufacturers Industry Stocks (WLLW)

Profile

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2025 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.